Neil Dahiya

Biocon Biologics, a division of Biocon, announced the green light from the US Food and Drug Administration (FDA) for Yesintek (ustekinumab-kfce), a biosimilar comparable to Stelara (ustekinumab). Yesintek, a monoclonal antibody, has been sanctioned for addressing conditions such as Crohn’s […]

Aster DM Healthcare and Quality Care India Limited (QCIL), a prominent Indian hospital network supported by Blackstone and TPG, have formalized an agreement for a merger. This action has been sanctioned by the companies’ boards and awaits necessary regulatory, corporate,

Amrita Vishwa Vidyapeetham’s Amritapuri campus hosted ALARM 2024 (Amrita Legion for Antimicrobial Resistance Management) during World Antimicrobial Awareness Week (WAAW), which is celebrated worldwide from November 18 to 24. The program, conducted on November 22 and 23, was officially opened

Strand Life Sciences, a prominent player in genomics and bioinformatics, has introduced a blood-based screening tool aimed at the precocious identification of various cancers. CancerSpot leverages cutting-edge methylation profiling techniques that are internationally recognized to detect DNA fragments of cancerous

Biocon celebrated its 46th Founder’s Day with a host of inspiring and cohesive activities that paid tribute to its heritage, mission, and future outlook. Among the highlights was the inauguration of an Experience Centre. The Biocon Experience Center is a

Instructions for the sampling procedures of pharmaceuticals, cosmetics, and medical devices by Drugs Inspectors from both Central and State Drug Agencies dated 9th February, 2024

Proposed Rules for Pharmaceutical Distribution Excellence: Dated August 09, 2024

Agilus Diagnostics, a global leader specializing in pathology and radiology diagnostics, has introduced the revolutionary Claudin 18.2 test, setting a new benchmark in cancer diagnostics. This innovative step underscores Agilus Diagnostics’ ongoing dedication to pioneering diagnostic advancements. Gastric cancer ranks

Refeyn Ltd, a leader in mass photometry technology development and distribution for both industry and academia, has introduced a tailored software platform for automatic analysis of substantial mass photometry datasets. This new StreamlineMP software suite offers specialized analysis options, enhancing

Interim Diagnostic Imaging (IDI), in collaboration with its parent company, Modular Devices—a frontrunner in mobile imaging technologies—has launched a game-changing advancement in mobile medical imaging: an all-new 10′ wide Mobile MRI Scanner. This expanded-width trailer stands out as it is